BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 36233048)

  • 1. Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses.
    Wagh SK; Lammers KM; Padul MV; Rodriguez-Herrera A; Dodero VI
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut Microbiota in Celiac Disease and probiotics.
    Chibbar R; Dieleman LA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal microbiome and gluten in celiac disease.
    Wu X; Qian L; Liu K; Wu J; Shan Z
    Ann Med; 2021 Dec; 53(1):1797-1805. PubMed ID: 34647492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients.
    Marasco G; Cirota GG; Rossini B; Lungaro L; Di Biase AR; Colecchia A; Volta U; De Giorgio R; Festi D; Caio G
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32887325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity.
    Abdi F; Zuberi S; Blom JJ; Armstrong D; Pinto-Sanchez MI
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Therapeutic Strategies for Celiac Disease.
    Asri N; Rostami-Nejad M; Rezaei-Tavirani M; Razzaghi M; Asadzadeh-Aghdaei H; Zali MR
    Middle East J Dig Dis; 2020 Oct; 12(4):229-237. PubMed ID: 33564379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRX1 Deficiency Alters the Gut Microbiome and Is Further Exacerbated by Adherence to a Gluten-Free Diet.
    Morrison HA; Liu Y; Eden K; Nagai-Singer MA; Wade PA; Allen IC
    Front Immunol; 2022; 13():882521. PubMed ID: 35572547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Nondietary Therapies for Celiac Disease.
    Alhassan E; Yadav A; Kelly CP; Mukherjee R
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):335-345. PubMed ID: 31146067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review.
    Coto L; Mendia I; Sousa C; Bai JC; Cebolla A
    World J Gastroenterol; 2021 Oct; 27(37):6306-6321. PubMed ID: 34712034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: therapeutic targets for the pharmacologic management of coeliac disease-the future beyond a gluten-free diet.
    Klonarakis M; Andrews CN; Raman M; Panaccione R; Ma C
    Aliment Pharmacol Ther; 2022 May; 55(10):1277-1296. PubMed ID: 35229332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment.
    Verdu EF; Schuppan D
    Gastroenterology; 2021 Nov; 161(5):1395-1411.e4. PubMed ID: 34416277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies.
    Mohan M; Okeoma CM; Sestak K
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Drug Therapeutics in Celiac Disease: A Pipeline Review.
    Varma S; Krishnareddy S
    Drugs; 2022 Oct; 82(15):1515-1526. PubMed ID: 36251239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease.
    Crepaldi M; Palo M; Maniero D; Bertin L; Savarino EV; Anderson RP; Zingone F
    Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38275990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease.
    Francavilla R; Cristofori F; Vacca M; Barone M; De Angelis M
    Expert Rev Gastroenterol Hepatol; 2020 May; 14(5):323-333. PubMed ID: 32216476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of the gut microbiome in gluten-intolerance.
    Olivares M; Flor-Duro A; Sanz Y
    Curr Opin Clin Nutr Metab Care; 2021 Nov; 24(6):536-542. PubMed ID: 34622826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gluten Degrading Enzymes for Treatment of Celiac Disease.
    Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gluten-Free Diet in Co-Existent Celiac Disease and Type 1 Diabetes Mellitus: Is It Detrimental or Beneficial to Glycemic Control, Vascular Complications, and Quality of Life?
    Eland I; Klieverik L; Mansour AA; Al-Toma A
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gluten Immunogenic Peptides Are Not Correlated With Reported Adherence to Gluten-Free Diet in Children With Celiac Disease.
    Guz-Mark A; Perets TT; Biran N; Jack Y; Zevit N; Silbermintz A; Matar M; Nachmias-Friedler V; Waisbourd-Zinman O; Bar-Lev MR; Huta Y; Ashorov O; Gingold-Belfer R; Shamir R
    J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):244-248. PubMed ID: 37204826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiac disease: Hope for new treatments beyond a gluten-free diet.
    D'heedene M; Vanuytsel T; Wauters L
    Clin Nutr; 2024 Jun; 43(6):1240-1249. PubMed ID: 38648685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.